Inquiry Basket
| Catalog | Product Name | CAS Number |
|---|---|---|
| BADC-01461 | MC-betaglucuronide-MMAE-2 | |
| MC-betaglucuronide-MMAE-2 is part of an antibody-drug conjugate consisting of tubulin polymerization inhibitor MMAE and degradable ADC linker MC-betaglucuronide. | Inquiry | |
| BADC-01462 | N3-PEG4-DYKDDDD-Doxorubicin | |
| N3-PEG4-DYKDDDD-Doxorubicin is part of an antibody drug conjugate consisting of the anthracycline antibiotic Doxorubicin and a degradable ADC linker N3-PEG4-DYKDDDD. | Inquiry | |
| BADC-01463 | Azide-PEG4-VC-PAB-Doxorubicin | |
| Azide-PEG4-VC-PAB-Doxorubicin is composed of linker Azide-PEG4-VC-PAB and toxic molecule Doxorubicin, which can be used to prepare antibody-conjugated drugs. | Inquiry | |
| BADC-01464 | N3-PEG4-YPYDVPDYA-Doxorubicin | |
| N3-PEG4-YPYDVPDYA-Doxorubicin is part of an antibody drug conjugate consisting of the anthracycline antibiotic Doxorubicin and the degradable ADC linker N3-PEG4-YPYDVPDYA. | Inquiry | |
| BADC-01465 | MB-VC-MGBA | 932744-62-2 |
| MB-VC-MGBA is a part of antibody drug conjugates, which is formed by linking DNA alkylating agent MGBA and ADC linker MB-VC. | Inquiry | |
| BADC-01466 | Desmethyl Vc-seco-DUBA | |
| Desmethyl Vc-seco-DUBA is an innovative biomedical product used in the treatment of various diseases. It exhibits potent anti-inflammatory properties, making it effective in managing chronic inflammation associated with autoimmune disorders. Its precise mechanism of action involves specifically targeting the overactive immune response and modulating inflammatory pathways. By alleviating inflammation, Desmethyl Vc-seco-DUBA offers promising therapeutic potential in conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. | Inquiry | |
| BADC-01467 | Lys-Nε-SPDB-DM4 | 1280215-91-9 |
| Lys-Nε-SPDB-DM4 is a drug-linker conjugate consisting of the potent tubulin inhibitor DM4 and the linker Lys-Nε-SPDB for the preparation of antibody-drug conjugates (ADCs). | Inquiry | |
| BADC-01468 | DM1-PEG4-DBCO | |
| DM1-(PEG)4-DBCO is a drug conjugate (ADC) consisting of the tubulin inhibitor DM1 and the linker DBCO-PEG4-Ahx. Mertansin (DM1), a tubulin inhibitor, is an antibody-conjugated maytansine developed to overcome the systemic toxicity associated with maytansine and enhance tumor-specific delivery. | Inquiry | |
| BADC-01469 | Sulfo-SPDB-DGN462 | |
| Sulfo-SPDB-DGN462 is an extraordinary biomedicine chemical, exhibits unrivaled capabilities in combatting a multitude of diseases and ailments. Its mesmerizing prowess as an unparalleled inhibitor against a specific cadre of enzymes renders it immensely efficacious in curbing the malignant proliferation of cancer cells, subduing infirmities born out of inflammation, and addressing maladies pertaining to the neural system. | Inquiry | |
| BADC-01470 | MC-Val-Cit-PAB-dimethylDNA31 | 1639352-06-9 |
| MC-Val-Cit-PAB-dimethylDNA31 has a bioreversible linkage based on a quaternary ammonium for targeted delivery and it can improve pharmacokinetics and the therapeutic index. MC-Val-Cit-PAB-dimethylDNA31 is used for the antibody-drug conjugates (ADC) that are effective and stable in vitro and in vivo to treat various diseases or disorders. | Inquiry | |
| BADC-01471 | TLR7/8 agonist 4 hydroxy-PEG10-acid | 2388520-17-8 |
| TLR7/8 agonist 4 hydroxy-PEG10-acid (compound 9) is part of an antibody-drug conjugate composed of TLR7/8 activator TLR7/8 agonist 4 (HY-139018) and degradable ADC linker hydroxy-PEG10- acid (HY-133307) concatenated. | Inquiry | |
| BADC-01472 | MAC-VC-PABC-ST7612AA1 | |
| MAC-VC-PABC-ST7612AA1 is part of Antibody Drug Conjugate ADCs with HDAC inhibitor payload and linker for antitumor activity. | Inquiry | |
| BADC-01473 | MC-VC-PABC-SP 141 | |
| MC-VC-PABC-SP 141 is part of an antibody-drug conjugate, which is composed of a potent MDM2 inhibitor SP 141 and a degradable ADC linker MC-VC-PABC. | Inquiry | |
| BADC-01474 | PSMA-ALB-56 | 2306049-48-7 |
| PSMA-ALB-56 is a PSMA-targeting radioligand consisting of a glutamate-urea PSMA-binding entity and an albumin conjugate. | Inquiry | |
| BADC-01475 | N3-PEG8-Phe-Lys-PABC-Gefitinib | |
| N3-PEG8-Phe-Lys-PABC-Gefitinib is composed of anticancer drug Gefitinib (an oral active inhibitor) and degradable ADC linker N3-PEG8-Phe-Lys-PABC. | Inquiry | |
| BADC-01476 | FCHFHS-ST7612AA1 | |
| FCHFHS-ST7612AA1 is part of Antibody Drug Conjugate ADCs with HDAC inhibitor payload and linker for antitumor activity. | Inquiry | |
| BADC-01477 | PF-06380101 D8 | |
| PF-06380101 D8 (Aur0101 D8) is the deuterated version of PF-06380101. PF-06380101 is an Auristatin microtubule inhibitor, a cytotoxic Dolastatin 10 analogue. | Inquiry | |
| BADC-01478 | D8-MMAF | |
| D8-MMAF hydrochloride is the deuterated form of MMAF hydrochloride. MMAF Hydrochloride is a potent tubulin polymerization inhibitor used as a cytotoxic component of antineoplastic drugs and antibody drug conjugates (ADCs). | Inquiry | |
| BADC-01479 | 7-MAD-MDCPT | 765871-81-6 |
| 7-MAD-MDCPT, a camptothecin analog, is the active moiety in an antibody drug conjugate (ADC). | Inquiry | |
| BADC-01486 | Dimethyl-SGD-1882 | |
| Dimethyl-SGD-1882 (Dimethyl-PBD dimer) is a highly efficient DNA alkylator (DNA alkylator), which can be used as the toxin moiety of antibody drug conjugate (ADC). PBD Dimer is a DNA alkylating agent that inhibits DNA replication. | Inquiry |
